| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-05-11 16:56:22 UTC |
|---|
| Updated at | 2022-05-11 16:56:23 UTC |
|---|
| NP-MRD ID | NP0087668 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA |
|---|
| Description | 3A,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA, also known as 24-oxo-25(R)-trihydroxycoprostanoyl-CoA or R-trhoccoa, belongs to the class of organic compounds known as 3-oxo-acyl coas. These are organic compounds containing a 3-oxo acylated coenzyme A derivative. 3A,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA is a strong basic compound (based on its pKa). Within humans, 3a,7a,12a-trihydroxy-5b-24-oxocholestanoyl-CoA participates in a number of enzymatic reactions. In particular, 3a,7a,12a-trihydroxy-5b-24-oxocholestanoyl-CoA can be biosynthesized from 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoic acid through the action of the enzyme bile acyl-CoA synthetase. In addition, 3a,7a,12a-trihydroxy-5b-24-oxocholestanoyl-CoA can be converted into 3a,7a,12a-trihydroxy-5b-24-oxocholestanoyl-CoA through the action of the enzyme Alpha-methylacyl-CoA racemase. In humans, 3a,7a,12a-trihydroxy-5b-24-oxocholestanoyl-CoA is involved in cerebrotendinous xanthomatosis (ctx). They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids have potent toxic properties (e.G., Membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. 3A,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA is an intermediate in bile acid synthesis. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. |
|---|
| Structure | [H][C@@]12CCC(C(C)CCC(=O)C(C)C(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3OP(O)(O)=O)N3C=NC4=C3N=CN=C4N)C1(C)[C@@H](O)C[C@@]1([H])C2[C@H](O)C[C@]2([H])C[C@H](O)CCC12C InChI=1S/C48H78N7O21P3S/c1-24(28-8-9-29-36-30(19-34(59)48(28,29)6)47(5)13-11-27(56)17-26(47)18-32(36)58)7-10-31(57)25(2)45(64)80-16-15-50-35(60)12-14-51-43(63)40(62)46(3,4)21-73-79(70,71)76-78(68,69)72-20-33-39(75-77(65,66)67)38(61)44(74-33)55-23-54-37-41(49)52-22-53-42(37)55/h22-30,32-34,36,38-40,44,56,58-59,61-62H,7-21H2,1-6H3,(H,50,60)(H,51,63)(H,68,69)(H,70,71)(H2,49,52,53)(H2,65,66,67)/t24?,25?,26-,27+,28?,29-,30-,32+,33+,34-,36?,38+,39+,40?,44+,47?,48?/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (24R,25R)-3-alpha,7-alpha,12-alpha,24-Tetrahydroxy-5-beta-cholestan-26-oyl-CoA | HMDB | | (24R,25R)-3-alpha,7-alpha,12-alpha,24-Tetrahydroxy-5-beta-cholestan-26-oyl-coenzyme A | HMDB | | 24-oxo-25(R)-Trihydroxycoprostanoyl-CoA | HMDB | | 24-oxo-25(R)-Trihydroxycoprostanoyl-coenzyme A | HMDB | | 25(R)-24-oxo-3alpha,7alpha,12alpha-Trihydroxycoprostanoyl-CoA | HMDB | | 25(R)-24-oxo-3alpha,7alpha,12alpha-Trihydroxycoprostanoyl-coenzyme A | HMDB | | 25(R)-3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholestanoyl-CoA | HMDB | | 25(R)-3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholestanoyl-coenzyme A | HMDB | | 25(R)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-24-on-26-oyl-CoA | HMDB | | 25(R)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-24-on-26-oyl-coenzyme A | HMDB | | 25(R)-5beta-Cholestane-3alpha,7alpha,12alpha-triol-24-on-26-oyl-CoA | HMDB | | 25(R)-5beta-Cholestane-3alpha,7alpha,12alpha-triol-24-on-26-oyl-coenzyme A | HMDB | | 3-alpha,7-alpha,12-alpha,24-Tetrahydroxy-5-beta-cholestan-26-oyl-CoA | HMDB | | 3-alpha,7-alpha,12-alpha,24-Tetrahydroxy-5-beta-cholestan-26-oyl-coenzyme A | HMDB | | 3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-beta-cholestanoyl-CoA | HMDB | | 3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-beta-cholestanoyl-coenzyme A | HMDB | | 3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-coenzyme A | HMDB | | 3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholestanoyl-CoA | HMDB | | 3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholestanoyl-coenzyme A | HMDB | | 3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA | HMDB | | 3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-coenzyme A | HMDB | | R-TrHOCCoA | HMDB | | R-TrHOCcoenzyme A | HMDB |
|
|---|
| Chemical Formula | C48H78N7O21P3S |
|---|
| Average Mass | 1214.1540 Da |
|---|
| Monoisotopic Mass | 1213.41843 Da |
|---|
| IUPAC Name | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy({3-hydroxy-2,2-dimethyl-3-[(2-{[2-({2-methyl-3-oxo-6-[(1S,5R,7S,9R,11S,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]heptanoyl}sulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]propoxy})phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid |
|---|
| Traditional Name | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[({hydroxy[hydroxy(3-hydroxy-2,2-dimethyl-3-[(2-{[2-({2-methyl-3-oxo-6-[(1S,5R,7S,9R,11S,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]heptanoyl}sulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]propoxy)phosphoryl]oxyphosphoryl}oxy)methyl]oxolan-3-yl]oxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@]12CCC(C(C)CCC(=O)C(C)C(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3OP(O)(O)=O)N3C=NC4=C3N=CN=C4N)C1(C)[C@@H](O)C[C@@]1([H])C2[C@H](O)C[C@]2([H])C[C@H](O)CCC12C |
|---|
| InChI Identifier | InChI=1S/C48H78N7O21P3S/c1-24(28-8-9-29-36-30(19-34(59)48(28,29)6)47(5)13-11-27(56)17-26(47)18-32(36)58)7-10-31(57)25(2)45(64)80-16-15-50-35(60)12-14-51-43(63)40(62)46(3,4)21-73-79(70,71)76-78(68,69)72-20-33-39(75-77(65,66)67)38(61)44(74-33)55-23-54-37-41(49)52-22-53-42(37)55/h22-30,32-34,36,38-40,44,56,58-59,61-62H,7-21H2,1-6H3,(H,50,60)(H,51,63)(H,68,69)(H,70,71)(H2,49,52,53)(H2,65,66,67)/t24?,25?,26-,27+,28?,29-,30-,32+,33+,34-,36?,38+,39+,40?,44+,47?,48?/m0/s1 |
|---|
| InChI Key | AWLXQJGPNLCTLM-XFQWJXLTSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 3-oxo-acyl coas. These are organic compounds containing a 3-oxo acylated coenzyme A derivative. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Fatty acyl thioesters |
|---|
| Direct Parent | 3-oxo-acyl CoAs |
|---|
| Alternative Parents | |
|---|
| Substituents | - Coenzyme a or derivatives
- Purine ribonucleoside 3',5'-bisphosphate
- Purine ribonucleoside bisphosphate
- Purine ribonucleoside diphosphate
- Steroidal glycoside
- Trihydroxy bile acid, alcohol, or derivatives
- 24-oxosteroid
- Hydroxy bile acid, alcohol, or derivatives
- Cholane-skeleton
- Bile acid, alcohol, or derivatives
- 3-hydroxysteroid
- 12-hydroxysteroid
- Hydroxysteroid
- Oxosteroid
- 3-alpha-hydroxysteroid
- 7-hydroxysteroid
- Steroid
- Ribonucleoside 3'-phosphate
- Pentose phosphate
- Pentose-5-phosphate
- Beta amino acid or derivatives
- Glycosyl compound
- N-glycosyl compound
- Organic pyrophosphate
- 6-aminopurine
- Pentose monosaccharide
- Monosaccharide phosphate
- Purine
- Imidazopyrimidine
- Aminopyrimidine
- Monoalkyl phosphate
- Monosaccharide
- N-acyl-amine
- N-substituted imidazole
- Phosphoric acid ester
- Pyrimidine
- Fatty amide
- 1,3-dicarbonyl compound
- Alkyl phosphate
- Organic phosphoric acid derivative
- Imidolactam
- Azole
- Cyclic alcohol
- Tetrahydrofuran
- Imidazole
- Heteroaromatic compound
- Thiocarboxylic acid ester
- Ketone
- Amino acid or derivatives
- Secondary alcohol
- Carboxamide group
- Secondary carboxylic acid amide
- Carbothioic s-ester
- Polyol
- Organoheterocyclic compound
- Azacycle
- Thiocarboxylic acid or derivatives
- Oxacycle
- Sulfenyl compound
- Carboxylic acid derivative
- Organooxygen compound
- Organic oxygen compound
- Organopnictogen compound
- Carbonyl group
- Organic nitrogen compound
- Alcohol
- Hydrocarbon derivative
- Organic oxide
- Primary amine
- Amine
- Organosulfur compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|